Clinical predictors of survival for elderly patients with esophageal squamous cell carcinoma

Abstract Prognostic factors for poor survival have been proposed in esophageal squamous cell carcinoma (SCC) patients receiving concurrent chemoradiotherapy (CRT). However, little is known about the association of pretreatment platelet‐to‐lymphocyte ratio (PLR) and neutrophil‐to‐lymphocyte (NLR) levels and treatment outcomes in elderly SCC patients. We conducted a retrospective study of elderly patients with esophageal SCC to find out clinical factors affecting survival. From January 2008 to December 2017, a total of 106 esophageal SCC patients with age more than 65 years old were enrolled. All included patients had undergone either concurrent CRT or radiotherapy (RT). Complete blood count, differential count, NLR, and PLR were obtained before treatment. Univariate and multivariate Cox regression analyses were used to assess the association between survival and patient, disease, and treatment characteristics. Seventy‐five patients received CRT, while the remaining 31 patients were treated with RT alone. Multivariate analysis showed that CRT ( p = .03, hazard ratio [HR] [95% confidence interval, CI] = 0.589 [0.365–0.95]), female ( p = .011, HR [95% CI] = 0.216 [0.066–0.703]), ECOG performance status 0–I ( p < .001, HR [95% CI] = 3.514 [2.049–6.026]), hemoglobin (Hb) ≥12 g/dL ( p < .01, HR [95% CI] = 0.57 [0.37–0.878]) were independent factors for predicting better overall survival (OS). Independent factors for predicting better disease‐specific survival (DSS) included ECOG performance status 0–I ( p < .001, HR [95% CI] = 3.147 [1.802–5.497]), Clinical staging I–II ( p = .023, HR [95% CI] = 2.124 [1.112–4.060]) and, NLR <5.3 ( p = .029, HR [95% CI] = 1.706 [1.058–2.752]). Our study showed that CRT, gender, ECOG performance status, Hb level, were independent predictors of OS; whereas ECOG performance status, clinical staging and NLR were independent predictors of DSS. Pretreatment NLR >5.3 is an independent poor prognostic factor for DSS of elderly esophageal SCC patients. Because our study is a retrospective analysis, further prospective studies are needed to validify the findings in our study.

Authors

Institutions

Publication Details

Journal
Advances in digestive medicine
Published
2025-03-01
DOI
https://doi.org/10.1002/aid2.13423
Primary Topic
Esophageal Cancer Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical predictors of survival for elderly patients with esophageal squamous cell carcinoma

Sheng‐Lei Yan, Kuan‐Ming Lai, Chien‐Yu Tsai
1 links
Advances in digestive medicine
Esophageal Cancer Research and Treatment
article

Clinical predictors of survival for elderly patients with esophageal squamous cell carcinoma

Sheng‐Lei Yan, Kuan‐Ming Lai, Chien‐Yu Tsai
article en

Abstract

Abstract Prognostic factors for poor survival have been proposed in esophageal squamous cell carcinoma (SCC) patients receiving concurrent chemoradiotherapy (CRT). However, little is known about the association of pretreatment platelet‐to‐lymphocyte ratio (PLR) and neutrophil‐to‐lymphocyte (NLR) levels and treatment outcomes in elderly SCC patients. We conducted a retrospective study of elderly patients with esophageal SCC to find out clinical factors affecting survival. From January 2008 to December 2017, a total of 106 esophageal SCC patients with age more than 65 years old were enrolled. All included patients had undergone either concurrent CRT or radiotherapy (RT). Complete blood count, differential count, NLR, and PLR were obtained before treatment. Univariate and multivariate Cox regression analyses were used to assess the association between survival and patient, disease, and treatment characteristics. Seventy‐five patients received CRT, while the remaining 31 patients were treated with RT alone. Multivariate analysis showed that CRT ( p = .03, hazard ratio [HR] [95% confidence interval, CI] = 0.589 [0.365–0.95]), female ( p = .011, HR [95% CI] = 0.216 [0.066–0.703]), ECOG performance status 0–I ( p < .001, HR [95% CI] = 3.514 [2.049–6.026]), hemoglobin (Hb) ≥12 g/dL ( p < .01, HR [95% CI] = 0.57 [0.37–0.878]) were independent factors for predicting better overall survival (OS). Independent factors for predicting better disease‐specific survival (DSS) included ECOG performance status 0–I ( p < .001, HR [95% CI] = 3.147 [1.802–5.497]), Clinical staging I–II ( p = .023, HR [95% CI] = 2.124 [1.112–4.060]) and, NLR <5.3 ( p = .029, HR [95% CI] = 1.706 [1.058–2.752]). Our study showed that CRT, gender, ECOG performance status, Hb level, were independent predictors of OS; whereas ECOG performance status, clinical staging and NLR were independent predictors of DSS. Pretreatment NLR >5.3 is an independent poor prognostic factor for DSS of elderly esophageal SCC patients. Because our study is a retrospective analysis, further prospective studies are needed to validify the findings in our study.

Advances in digestive medicineVol. 12(1)
Dayeh University (TW), Chang Bing Show Chwan Memorial Hospital (TW), Changhua Christian Hospital (TW)
Openalex Percentile: Top 92%
Esophageal Cancer Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.